Heart Failure Clinical Trial
Official title:
Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events
To explore the role of insulin growth factor in cardiovascular disease in older men and women.
BACKGROUND:
Insulin-like growth factor-I (IGF-I) is the main mediator of effects of growth hormone (GH)
and an important regulator of cell cycle/differentiation and inhibitor of apoptosis.
Consistent with laboratory studies showing potentially beneficial effects of IGF-I on the
cardiovascular and cerebrovascular systems, GH-deficient individuals have high cardiovascular
disease (CVD) mortality and evidence of premature atherosclerotic disease that is reversible
with GH replacement. In addition, several epidemiological and clinical studies have shown an
association between low serum IGF-I levels and myocardial infarction (MI) and congestive
heart failure (CHF) among persons without frank abnormalities of the GH/IGF-I axis.
DESIGN NARRATIVE:
The study is the first prospective investigation to assess whether serum levels of IGF-I and
two of its important binding proteins, IGFBP-3, and IGFBP-1, are associated with incidence of
confirmed incident cardiovascular disease (CVD) events in older male and female adults.
Specimens and data for this study will be obtained from the Cardiovascular Health Study
(CHS), a large, multi-center NHLBI-funded prospective cohort study of 5,888
community-dwelling men and women 65 years or older. The study uses an efficient case-cohort
study design to select specimens for testing, involving evaluation of 750 incident myocardial
infarction (MI)/fatal coronary heart disease (CHD) cases, 500 incident stroke cases, 750
incident congestive heart failure (CHF) cases, and a comparison sub-cohort of 750 individuals
selected at random from the study population. The study examines the association between
baseline serum IGF-I, IGFBP-1, and IGFBP-3 level and the future occurrence of first incident
MI/fatal CHD, ischemic stroke, and CHF. Multivariate regression models are used to control
for potential confounding factors including age, sex, race/ethnicity, anthropometry and body
composition, fasting and 2-hour post-load glucose and insulin levels, dietary intake,
physical activity, hormone replacement therapy and other medications, and other CVD risk
markers such as lipids, inflammatory factors, and coagulation/fibrinolysis markers.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
| Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
| Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
| Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
| Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
| Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
| Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
| Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
| Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
| Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
| Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
| Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
| Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
| Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|